KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.Clin Cancer ResPMID 35552673PMC96629222022-Aug-150.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.CancerPMID 35727053PMC114972502022-Aug-150.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.VaccinePMID 35810063无 PMCID2022-Aug-120.98未发现恶性肿瘤人群证据。待处理
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma.Blood AdvPMID 35594559PMC96363272022-Aug-090.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.J Natl Cancer InstPMID 35512402PMC93604612022-Aug-080.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis.Arthritis Res TherPMID 35941676PMC93589052022-Aug-080.98未发现恶性肿瘤人群证据。待处理
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.LancetPMID 35934006无 PMCID2022-Aug-060.85The record meets criteria for oncology, human, randomized, Phase III, and time-to-event efficacy endpoint. However, it does not include a drug-containing intervention; the study compares radiation dose and fractionation schedules (radiation therapy) with or without a tumor bed boost, which is a radiation-based intervention, not a drug. The inclusion criteria require a drug-containing intervention.待处理
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial.Jpn J Clin OncolPMID 35640246PMC93545012022-Aug-050.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial.BMC Infect DisPMID 35927676PMC93512572022-Aug-040.98未发现恶性肿瘤人群证据。待处理
Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid.J Am Heart AssocPMID 35916348PMC93754712022-Aug-020.98未发现恶性肿瘤人群证据。待处理
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).J Clin OncolPMID 35298280PMC76146642022-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancer.Int J Gynecol CancerPMID 35321888无 PMCID2022-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.J Acquir Immune Defic SyndrPMID 35344520PMC93429482022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.J Clin OncolPMID 35394800PMC94676802022-Aug-010.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial.J Clin OncolPMID 35404684无 PMCID2022-Aug-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).Int J CancerPMID 35411939PMC93219952022-Aug-010.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.Int J Radiat Oncol Biol PhysPMID 35568246无 PMCID2022-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.JAMA OncolPMID 35653145PMC91641172022-Aug-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study.J Clin RheumatolPMID 35653615PMC93365742022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.JAMA OphthalmolPMID 35708706PMC92046222022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.J Clin OncolPMID 35709465无 PMCID2022-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.JAMA DermatolPMID 35830173PMC92806112022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Acceptability of Telerehabilitation for Magnification Devices for the Visually Impaired Using Various Approaches to Facilitate Accessibility.Transl Vis Sci TechnolPMID 35917136PMC93582942022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial.JAMA Netw OpenPMID 35997978PMC93998782022-Aug-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis.Clin Gastroenterol HepatolPMID 33127596无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).Br J OphthalmolPMID 33712478PMC93400302022-Aug0.98未发现恶性肿瘤人群证据。待处理
Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: post hoc pooled analysis from PALLADIUM and IRIDIUM studies.J AsthmaPMID 34346266无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients.Pharm ResPMID 35233731PMC93143062022-Aug0.98未发现恶性肿瘤人群证据。待处理
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.AllergyPMID 35266148PMC93569722022-Aug0.98未发现恶性肿瘤人群证据。待处理
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial.J RheumatolPMID 35428718无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND).J Am Acad DermatolPMID 35439608无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.Diabetes Obes MetabPMID 35441470PMC95422522022-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.J Bone Miner ResPMID 35466448PMC95443352022-Aug0.98未发现恶性肿瘤人群证据。待处理
A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).Ann Surg OncolPMID 35524087无 PMCID2022-Aug0.99记录类型属于综述、Meta 分析、社论、评论、病例或指南。待处理
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.EpilepsiaPMID 35582748PMC95413902022-Aug0.98未发现恶性肿瘤人群证据。待处理
Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo-controlled feasibility clinical trial.SurgeryPMID 35606184无 PMCID2022-Aug0.85The study is a randomized, placebo-controlled pilot/feasibility trial in human oncology patients. However, it fails inclusion due to: 1) The intervention is nutritional supplements (non-drug), not a drug-containing intervention. 2) It is a Phase II/feasibility study, not a definitive Phase III trial. 3) The primary endpoint is enrollment feasibility, and secondary endpoints include compliance and postoperative complications (not time-to-event efficacy like OS, PFS, DFS). No Kaplan-Meier or HR is reported for an efficacy endpoint.待处理
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation.Bone Marrow TransplantPMID 35610308PMC93525702022-Aug0.95Meets all eligibility criteria: Phase III randomized oncology trial in humans with a drug intervention and primary/key secondary time-to-event efficacy endpoint (PFS).待处理
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.Am J HematolPMID 35617104无 PMCID2022-Aug0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Efficacy and safety of PavéDerm J-Fill for nasolabial folds: A phase III randomized, blinded, prospective, and split-faced head-to-head trial.Dermatol TherPMID 35642570无 PMCID2022-Aug0.99记录类型属于综述、Meta 分析、社论、评论、病例或指南。待处理
Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi-centre, non-inferiority, randomized, controlled phase 3 clinical trial.Basic Clin Pharmacol ToxicolPMID 35653554PMC95436202022-Aug0.98未发现恶性肿瘤人群证据。待处理
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.Lancet Respir MedPMID 35662406无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.BreastPMID 35691249PMC91900512022-Aug0.90Study is a Phase II, single-arm trial investigating radiotherapy (non-drug intervention), not a randomized Phase III trial with a drug-containing intervention.待处理
Ovarian reserve in premenopausal women with breast cancer.BreastPMID 35691250PMC91944522022-Aug0.85The record is from a definitive phase III randomized oncology trial, but it reports on ovarian reserve biomarker changes (AMH), not the required survival, progression, recurrence, death, or time-to-event efficacy outcomes.待处理
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study.Fertil SterilPMID 35710599无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.Adv TherPMID 35716319PMC93091202022-Aug0.98未发现恶性肿瘤人群证据。待处理
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.Lancet HaematolPMID 35777413无 PMCID2022-Aug0.98未发现恶性肿瘤人群证据。待处理
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.Lancet HaematolPMID 35779558PMC92435682022-Aug0.98未发现恶性肿瘤人群证据。待处理
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.Lancet HaematolPMID 35779560PMC92435702022-Aug0.98未发现恶性肿瘤人群证据。待处理
Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life.ESMO OpenPMID 35785595PMC94341662022-Aug0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.Lancet OncolPMID 35798016无 PMCID2022-Aug1.00命中用户提供的消化道肿瘤阳性参考集。待处理